Novel drug metabolism indices for pharmacogenetic functional status based on combinatory genotyping ofCYP2C9,CYP2C19andCYP2D6genes

DNA Microarray Technology in the Clinical Environment: The AmpliChip CYP450 Test for CYP2D6 and CYP2C19 Genotyping

(2016) Jose de Leon et al.   CNS SPECTRUMS

Physiogenomic analysis of CYP450 drug metabolism correlates dyslipidemia with pharmacogenetic functional status in psychiatric patients

(2011) Gualberto Ruaño et al.   Biomarkers in Medicine

Successes Achieved and Challenges Ahead in Translating Biomarkers into Clinical Applications

(2010) Greg Tesch et al.   AAPS Journal

Composite Functional Genetic and Comedication CYP2D6 Activity Score in Predicting Tamoxifen Drug Exposure Among Breast Cancer Patients

(2010) Silvana Borges et al.   JOURNAL OF CLINICAL PHARMACOLOGY

The past, present and future of pharmacoepigenomics

(2010) Magnus Ingelman-Sundberg et al.   PHARMACOGENOMICS

Polymorphism of Human Cytochrome P450 2D6 and Its Clinical Significance

(2009) Shu-Feng Zhou   CLINICAL PHARMACOKINETICS

Relation betweenCYP2D6genotype, personality, neurocognition and overall psychopathology in healthy volunteers

(2009) Eva M Peñas-LLedó et al.   PHARMACOGENOMICS

Intermediate metabolizer: increased side effects in psychoactive drug therapy. The key to cost-effectiveness of pretreatment CYP2D6 screening?

(2009) B Laika et al.   PHARMACOGENOMICS JOURNAL

Pharmacogenetic Testing in Psychiatry: A Review of Features and Clinical Realities

(2008) José de Leon et al.   CLINICS IN LABORATORY MEDICINE

Semi-quantitative CYP2D6 gene doses in relation to metabolic ratios of psychotropics

(2008) John W. J. Hinrichs et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Increased carrier prevalence of deficientCYP2C9,CYP2C19andCYP2D6alleles in depressed patients referred to a tertiary psychiatric hospital

(2008) Gualberto Ruaño et al.   Personalized Medicine